. Subgroup analysis in the PVR group after propensity score matching. Subgroup analysis for various factors, including (A) PV invasion, (B) TNM stage, (C) LN metastasis, (D) BMI (kg/m 2 ), (E) ALB (g/l), (F) R1 resection (microscopic positive margin), (G) CA 125 (U/ml) and (H) CA 19-9 (U/ml) after propensity score matching. PV, portal vein; PVR, portal vein resection; TNM, Tumor-Node-Metastasis; BMI, body mass index; ALB, albumin; CA 125, carbohydrate antigen 125; CA 19-9, carbohydrate antigen 19-9; LN, lymph node. Figure S3 . Subgroup analysis in the non-PVR group before propensity score matching. Subgroup analysis for various factors, including (A) TNM stage, (B) LN metastasis, (C) BMI (kg/m 2 ), (D) ALB (g/l), (E) R1 resection (microscopic positive margin), (F) CA 125 (U/ml) and (G) CA 19-9 (U/ml) before propensity score matched. PV, portal vein; PVR, portal vein resection; TNM, Tumor-Node-Metastasis; BMI, body mass index; ALB, albumin; CA 125, carbohydrate antigen 125; CA 19-9, carbohydrate antigen 19-9; LN, lymph node. Figure S4 . Subgroup analysis in the non-PVR group after propensity score matching. Subgroup analysis for various factors, including (A) TNM stage, (B) LN metastasis, (C) BMI (kg/m 2 ), (D) ALB (g/l), (E) R1 resection (microscopic positive margin), (F) CA 125 (U/ml) and (G) CA 19-9 (U/ml) after propensity score matching. PV, portal vein; PVR, portal vein resection; TNM, Tumor-Node-Metastasis; BMI, body mass index; ALB, albumin; CA 125, carbohydrate antigen 125; CA 19-9, carbohydrate antigen 19-9; LN, lymph node. 
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